Health Economic Models

These health economic models calculate the impact of aspirin adherence on healthcare costs and quality adjusted life years in patients with a prior cardiovascular event from a payer perspective. The “no diabetes” model is for patients with a history of cardiovascular disease who do not have diabetes as a comorbid condition. The “diabetes” model is for patients with a history of cardiovascular disease who have type II diabetes as a comorbid condition. These .trex files are designed to be loaded and run in TreeAge software Pro Core 2016 health economic modeling software.

Data associated with the following article: https://link.springer.com/article/10.1007%2Fs41669-018-0075-2

Laurence M. Djatche, Stefan Varga, and Robert D. Lieberthal. "Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events." PharmacoEconomics 2018